Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

Rhea-AI Summary

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced upcoming investor events for September 2024. These include presentations at two major healthcare conferences: the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 and the 2024 Wells Fargo Healthcare Conference on September 5. Additionally, Regeneron will host an oncology-focused webcast on September 16, coinciding with the European Society for Medical Oncology (ESMO) 2024 conference. This webcast will provide updates on the company's oncology portfolio. All events will be accessible via Regeneron's investor relations website, with replays and transcripts available for at least 30 days after each event.

Positive

• Participation in two major healthcare investor conferences
• Dedicated oncology portfolio update webcast planned

Negative

• None.

TARRYTOWN, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announces the following September 2024 investor events:

Investor Conference Presentations

• Morgan Stanley 22^nd Annual Global Healthcare Conference at 11:30 a.m. ET on
Wednesday, September 4, 2024

• 2024 Wells Fargo Healthcare Conference at 12:45 p.m. ET on Thursday,
September 5, 2024

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

Oncology Webcast Information

• European Society for Medical Oncology (ESMO) 2024 conference call and webcast at 14:30 CEST/8:30 AM EDT on Monday, September 16, 2024

Regeneron will host a conference call and simultaneous webcast to share updates on the company’s oncology portfolio. A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at https://investor.regeneron.com/events-and-presentations. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com

FAQ

When is Regeneron (REGN) presenting at the Morgan Stanley Global Healthcare Conference in 2024?

Regeneron (REGN) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 11:30 a.m. ET.

What time is Regeneron's (REGN) presentation at the 2024 Wells Fargo Healthcare Conference?

Regeneron (REGN) is scheduled to present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024, at 12:45 p.m. ET.

When is Regeneron (REGN) hosting its oncology portfolio update webcast in September 2024?

Regeneron (REGN) is hosting its oncology portfolio update webcast on Monday, September 16, 2024, at 14:30 CEST/8:30 AM EDT, coinciding with the ESMO 2024 conference.

Where can investors access Regeneron's (REGN) conference presentations and webcasts?

Investors can access Regeneron's (REGN) conference presentations and webcasts from the 'Investors & Media' page of the company's website at https://investor.regeneron.com/events-and-presentations.